I'll add - the webinar and press release showcased the trial results were good. For treating cancer. If you dont think that is bullish I can't help you.
I'll add - the webinar and press release showcased the trial results were good. For treating cancer. If you dont think that is bullish I can't help you.
I'll add - the webinar and press release showcased the trial results were good. For treating cancer. If you dont think that is bullish I can't help you.
Great news. Just not for my portfolio.
It will be double digits by month end and great for your portfolio
I'll add - the webinar and press release showcased the trial results were good. For treating cancer. If you dont think that is bullish I can't help you.
Great news. Just not for my portfolio.
It will be double digits by month end and great for your portfolio
Ill be sure to bump this thread to gloat.
Did you put all your best customers in it?
Moving my picks to Pack the Fudge. I don't like to lose $
I'll add - the webinar and press release showcased the trial results were good. For treating cancer. If you dont think that is bullish I can't help you.
Great news. Just not for my portfolio.
It will be double digits by month end and great for your portfolio
Ill be sure to bump this thread to gloat.
Did you put all your best customers in it?
Moving my picks to Pack the Fudge. I don't like to lose $
Are you a day trader? No, of course you're not
If a biotech stock dropping on good news is scary to your wallet then stick with Apple and MSFT
I'll add - the webinar and press release showcased the trial results were good. For treating cancer. If you dont think that is bullish I can't help you.
Great news. Just not for my portfolio.
It will be double digits by month end and great for your portfolio
Ill be sure to bump this thread to gloat.
Did you put all your best customers in it?
Moving my picks to Pack the Fudge. I don't like to lose $
Are you a day trader? No, of course you're not
If a biotech stock dropping on good news is scary to your wallet then stick with Apple and MSFT
Kind of like UWs moral victory over tOSU. They didn't win but it felt good.
I'll add - the webinar and press release showcased the trial results were good. For treating cancer. If you dont think that is bullish I can't help you.
Great news. Just not for my portfolio.
It will be double digits by month end and great for your portfolio
Ill be sure to bump this thread to gloat.
Did you put all your best customers in it?
Moving my picks to Pack the Fudge. I don't like to lose $
Are you a day trader? No, of course you're not
If a biotech stock dropping on good news is scary to your wallet then stick with Apple and MSFT
Kind of like UWs moral victory over tOSU. They didn't win but it felt good.
Yeah because the stock market only takes place one day out of the year and you only get a W or L. Great fucking analogy.
I'll add - the webinar and press release showcased the trial results were good. For treating cancer. If you dont think that is bullish I can't help you.
Great news. Just not for my portfolio.
It will be double digits by month end and great for your portfolio
Ill be sure to bump this thread to gloat.
Did you put all your best customers in it?
Moving my picks to Pack the Fudge. I don't like to lose $
Are you a day trader? No, of course you're not
If a biotech stock dropping on good news is scary to your wallet then stick with Apple and MSFT
Kind of like UWs moral victory over tOSU. They didn't win but it felt good.
Yeah because the stock market only takes place one day out of the year and you only get a W or L. Great fucking analogy.
Easy turbo. I just bought 500 shares. It better fucking move.
I'll add - the webinar and press release showcased the trial results were good. For treating cancer. If you dont think that is bullish I can't help you.
Great news. Just not for my portfolio.
It will be double digits by month end and great for your portfolio
Ill be sure to bump this thread to gloat.
Did you put all your best customers in it?
Moving my picks to Pack the Fudge. I don't like to lose $
Are you a day trader? No, of course you're not
If a biotech stock dropping on good news is scary to your wallet then stick with Apple and MSFT
Kind of like UWs moral victory over tOSU. They didn't win but it felt good.
Yeah because the stock market only takes place one day out of the year and you only get a W or L. Great fucking analogy.
Easy turbo. I just bought 500 shares. It better fucking move.
Look at you buying the dip. Im like a proud parent right now
Not familiar in ATOS...I do like to dabble in biotechs though. ATOS at $20 would put its market cap at a couple billion...pretty steep for a biotech with Phase 2 results and a pretty limited pipeline: https://atossatherapeutics.com/product-pipeline/ .
In my limited experience in bios they seem to work in levels...bioturds with <$100M market cap, promising early stage stuff with a market cap of $100MM<$500MM, and then breakthroughs that ramp up to a billion or so have a product that is a bolt-on for the big guys and a likely buyout candidate.
Give you a comparison of one I watch/own...PDSB. It has already run up a bunch but even with that run its only at a $250MM market cap (about half of ATOS), with pretty diverse pipeline and positive interim Phase 2 results: https://pdsbiotech.com/pipeline/oncology. Those results pushed it from bioturd to promising...will wait and see if they get further along to the breakthrough status.
Comments
inclusion in the Russell 3000 means funds that track/mimic will need to buy tons of shares to account for it being added
lots of positive momentum recently in anticipation of good news. Up 100% this month, many analysts saying this will easily go to double digits.
The real catalyst is the index inclusion. Nothing changed with my original post
Ill be sure to bump this thread to gloat.
Moving my picks to Pack the Fudge. I don't like to lose $
If a biotech stock dropping on good news is scary to your wallet then stick with Apple and MSFT
https://www.otcmarkets.com/stock/BLIAQ/profile
I did laugh
https://atossatherapeutics.com/product-pipeline/ .
In my limited experience in bios they seem to work in levels...bioturds with <$100M market cap, promising early stage stuff with a market cap of $100MM<$500MM, and then breakthroughs that ramp up to a billion or so have a product that is a bolt-on for the big guys and a likely buyout candidate.
Give you a comparison of one I watch/own...PDSB. It has already run up a bunch but even with that run its only at a $250MM market cap (about half of ATOS), with pretty diverse pipeline and positive interim Phase 2 results:
https://pdsbiotech.com/pipeline/oncology. Those results pushed it from bioturd to promising...will wait and see if they get further along to the breakthrough status.